Concepedia

Zhengyuan Zhou

ZZ

Statistics

Publications

24

Citations

716

H-Index

20

Active since

1999

Affiliations

Duke Medical Center(Current)

University of Nebraska Medical Center

Nebraska Medical Center

Duke University Hospital

Duke University

Zhengyuan Zhou is an author at Duke Medical Center specializing in oncology, medicine, and pharmacology.

Publications per year

1999–2022

24

Publications

24

Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy

Wenting Zhang, Wei Fan, Satyanarayana Rachagani et al. · Scientific Reports · 2019 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation

Zhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald et al. · Molecular Imaging and Biology · 2017 · 65 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17

An Efficient Method for Labeling Single Domain Antibody Fragments with <sup>18</sup>F Using Tetrazine-<i>Trans</i>-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker

Zhengyuan Zhou, Nick Devoogdt, Michael R. Zalutsky et al. · Bioconjugate Chemistry · 2018 · 45 citations

Pharmacy, Biotechnology, Pharmacology +17

Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation

Zhengyuan Zhou, Satish K. Chitneni, Michael R. Zalutsky et al. · Bioorganic & Medicinal Chemistry · 2018 · 36 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +5

Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[<sup>18</sup>F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios

Zhengyuan Zhou, Darryl McDougald, Nick Devoogdt et al. · Molecular Pharmaceutics · 2018 · 34 citations

Medicine, Oncology, Pharmacology +17

1–5 of 24